CVS
$92.36-0.24%
as of close, Oct 16, 2026
☾ AH $92.36 -0.24%
CVS Health CorporationStock · HealthcareS&P 500 Equal Weight 0.2%S&P 500 0.2%Russell 1000 0.2%Russell 3000 0.2%US Stock Market 0.2%MSCI ACWI 0.1%MSCI World 0.1%
CVS financial statements
The full income statement, balance sheet, and cash-flow statement for CVS Health Corporation (CVS), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 1.26B2024-09 1.26B2024-12 1.26B2025-03 1.27B2025-06 1.27B2025-09 1.27B2025-12 1.27B2026-03 1.28B2026-06 1.28B+1.7% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 402B+7.8% | 373B+4.2% | 358B+10.9% | 322B+10.4% | 292B+8.7% | |
| Cost of revenue | 221B+7.2% | 206B-5.0% | 217B+10.3% | 197B+12.0% | 176B+7.2% | |
| Amortization of intangibles | 1.98B-2.4% | 2.02B+6.3% | 1.91B+6.7% | 1.78B-20.1% | 2.23B-4.6% | |
| Operating income | 4.66B-45.3% | 8.52B-38.0% | 13.7B+72.8% | 7.95B-40.2% | 13.3B-4.3% | |
| Interest expense | 3.12B+5.4% | 2.96B+11.3% | 2.66B+16.2% | 2.29B-8.6% | 2.50B-13.9% | |
| Other non-operating income | 112M+13.1% | 99.0M+12.5% | 88.0M-47.9% | 169M-7.1% | 182M-11.7% | |
| Pre-tax income | 2.14B-65.3% | 6.15B-45.0% | 11.2B+91.4% | 5.84B-44.6% | 10.5B+7.9% | |
| Income tax | 408M-73.9% | 1.56B-44.3% | 2.81B+85.9% | 1.51B-40.8% | 2.55B-0.8% | |
| 1.77B-61.7% | 4.61B-44.7% | 8.34B+93.6% | 4.31B-46.1% | 8.00B+11.5% | ||
| Income from continuing operations | — | — | — | 4.15B-47.5% | 7.91B+10.0% | |
| Discontinued operations | — | — | — | 0.00 | 0.00+100.0% | |
| Net income to non-controlling interest | -40.0M-42.9% | -28.0M-216.7% | 24.0M+50.0% | 16.0M+233.3% | -12.0M-192.3% | |
| Net income to common | 1.77B-61.7% | 4.61B-44.7% | 8.34B+93.6% | 4.31B-46.1% | 8.00B | |
| $1.39-62.0% | $3.66-43.4% | $6.47+98.5% | $3.26-45.8% | $6.02+10.3% | ||
| EPS (basic) | $1.40-61.9% | $3.67-43.5% | $6.49+97.3% | $3.29-45.8% | $6.07+10.8% | |
| Weighted-avg shares (basic) | 1.27B+0.6% | 1.26B-2.0% | 1.28B-2.1% | 1.31B-0.5% | 1.32B+0.8% | |
| Weighted-avg shares (diluted) | 1.27B+0.7% | 1.26B-2.2% | 1.29B-2.5% | 1.32B-0.5% | 1.33B+1.1% | |
| Dividends per share | $2.66+0.0% | $2.66+9.9% | $2.42+10.0% | $2.20+10.0% | $2.00+0.0% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 74.7B+8.8% | 68.6B+1.2% | 67.9B+3.4% | 65.6B+9.4% | 60.0B+6.5% | ||
| Cash & equivalents | 8.45B-1.5% | 8.59B+4.8% | 8.20B-36.7% | 12.9B+37.6% | 9.41B+19.8% | |
| Short-term investments | 2.15B-10.9% | 2.41B-26.1% | 3.26B+17.3% | 2.78B-10.9% | 3.12B+3.9% | |
| Accounts receivable | 39.8B+9.1% | 36.5B+3.5% | 35.2B+29.2% | 27.3B+11.6% | 24.4B+12.4% | |
| Inventory | 19.2B+6.3% | 18.1B+0.5% | 18.0B-5.6% | 19.1B+7.5% | 17.8B-4.0% | |
| Other current assets | 5.09B+65.5% | 3.08B-2.4% | 3.15B+19.5% | 2.64B-50.2% | 5.29B+0.3% | |
| 254B+0.1% | 253B+1.4% | 250B+9.4% | 228B-2.0% | 233B+1.0% | ||
| Property, plant & equipment | — | — | — | 12.9B-0.2% | 12.9B+2.3% | |
| Operating lease right-of-use | 15.0B-6.1% | 15.9B-7.6% | 17.3B-3.5% | 17.9B-6.5% | 19.1B-7.8% | |
| Goodwill | 85.5B-6.3% | 91.3B+0.0% | 91.3B+16.8% | 78.2B-1.2% | 79.1B-0.5% | |
| Intangible assets | 25.5B-6.6% | 27.3B-6.5% | 29.2B+17.9% | 24.8B-14.5% | 29.0B-6.8% | |
| Long-term investments | 32.7B+12.9% | 28.9B+25.7% | 23.0B+9.1% | 21.1B-8.4% | 23.0B+10.6% | |
| Other non-current assets | 7.11B+48.4% | 4.79B+2.9% | 4.66B+0.9% | 4.62B-2.0% | 4.71B+1.9% | |
| 88.7B+4.8% | 84.6B+6.8% | 79.2B+14.1% | 69.4B+2.4% | 67.8B+9.3% | ||
| Accounts payable | 17.6B+11.0% | 15.9B+6.7% | 14.9B+0.4% | 14.8B+18.3% | 12.5B+12.6% | |
| Accrued liabilities | 22.4B+7.6% | 20.8B-11.5% | 23.5B+25.4% | 18.7B+6.1% | 17.7B+24.1% | |
| Deferred revenue | 62.0M-56.9% | 144M-3.4% | 149M+109.9% | 71.0M-18.4% | 87.0M+22.5% | |
| Short-term & current debt | 0.00-100.0% | 2.12B+959.5% | 200M | 0.00-100.0% | 4.21B | |
| Current lease liability | 1.74B-0.8% | 1.75B+0.6% | 1.74B+3.8% | 1.68B+1.9% | 1.65B+0.5% | |
| Finance lease liability (current) | 61.0M-6.2% | 65.0M-1.5% | 66.0M+11.9% | 59.0M+18.0% | 50.0M+51.5% | |
| 178B+0.4% | 177B+2.5% | 173B+10.6% | 157B-0.7% | 158B-2.1% | ||
| Long-term debt | 60.5B-0.0% | 60.5B+3.2% | 58.6B+16.2% | 50.5B-2.9% | 52.0B-12.2% | |
| Non-current lease liability | 13.6B-8.4% | 14.9B-7.1% | 16.0B-4.6% | 16.8B-7.6% | 18.2B-3.1% | |
| Operating lease liability (total) | 15.4B-7.6% | 16.6B-6.3% | 17.8B-4.1% | 18.5B-6.5% | 19.8B-2.8% | |
| Finance lease liability (total) | 1.33B-2.5% | 1.36B-2.2% | 1.39B-5.1% | 1.47B+12.7% | 1.30B+20.0% | |
| Finance lease liability | 1.26B-2.3% | 1.29B-2.3% | 1.32B-5.8% | 1.41B+12.5% | 1.25B+19.0% | |
| Deferred tax liabilities | 3.83B+0.7% | 3.81B-11.7% | 4.31B+7.3% | 4.02B-35.9% | 6.27B-7.7% | |
| Other non-current liabilities | 6.77B+24.7% | 5.43B-12.6% | 6.21B-7.7% | 6.73B+253.5% | 1.90B-19.0% | |
| 75.2B-0.5% | 75.6B-1.2% | 76.5B+7.0% | 71.5B-4.8% | 75.1B+8.2% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock | — | 18.0M+0.0% | 18.0M+0.0% | 18.0M+5.9% | 17.0M+0.0% | |
| Retained earnings | 61.2B-2.6% | 62.8B+2.0% | 61.6B+9.2% | 56.4B+2.7% | 54.9B+10.6% | |
| Treasury stock | 36.8B-0.1% | 36.8B+8.8% | 33.8B+6.2% | 31.9B+13.1% | 28.2B-0.0% | |
| Accumulated other comprehensive income | 406M+438.3% | -120M+59.6% | -297M+76.5% | -1.26B-231.0% | 965M-31.8% | |
| Non-controlling interest | 168M-1.2% | 170M-2.9% | 175M-41.7% | 300M-2.0% | 306M-1.9% | |
| Total equity incl. non-controlling | 75.4B-0.5% | 75.7B-1.2% | 76.6B+6.8% | 71.8B-4.1% | 74.8B+7.4% | |
| Total liabilities & equity | 254B+0.1% | 253B+1.4% | 250B+9.4% | 228B-2.0% | 233B+1.0% | |
| Common shares issued | 1.79B+0.5% | 1.78B+0.6% | 1.77B+0.6% | 1.76B+0.8% | 1.74B+0.6% | |
| Common shares outstanding | 1.27B+0.9% | 1.26B-2.2% | 1.29B-0.9% | 1.30B-1.7% | 1.32B+0.9% | |
| Shares outstanding (cover) | 1.27B+0.9% | 1.26B+0.2% | 1.26B-2.0% | 1.28B-2.2% | 1.31B+0.1% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 10.6B+16.8% | 9.11B-32.2% | 13.4B-17.0% | 16.2B-11.4% | 18.3B+15.1% | ||
| Depreciation & amortization | 4.61B+0.2% | 4.60B+5.3% | 4.37B+3.4% | 4.22B-5.8% | 4.49B+1.0% | |
| Intangible amortization | 1.98B-2.4% | 2.02B+6.3% | 1.91B+6.7% | 1.78B-20.1% | 2.23B-4.6% | |
| Share-based compensation | 535M-0.9% | 540M-8.2% | 588M+31.5% | 447M-7.6% | 484M+21.0% | |
| Deferred income taxes | 102M+117.8% | -572M+15.4% | -676M+66.7% | -2.03B-404.7% | -402M+28.7% | |
| Change in receivables | 3.50B+168.9% | 1.30B-79.2% | 6.26B+110.7% | 2.97B+9.9% | 2.70B+79.0% | |
| Change in inventory | 1.27B+1142.2% | 102M+108.3% | -1.23B-185.9% | 1.44B+295.2% | -735M-175.5% | |
| Change in payables | 3.85B+65.1% | 2.33B-35.5% | 3.62B-15.1% | 4.26B+47.0% | 2.90B+4.7% | |
| -5.87B+22.9% | -7.61B+63.6% | -20.9B-313.9% | -5.05B+4.1% | -5.26B+4.9% | ||
| Capital expenditure | 2.83B+1.8% | 2.78B-8.2% | 3.03B+11.1% | 2.73B+8.2% | 2.52B+3.4% | |
| Free cash flow | 7.81B+23.4% | 6.33B-39.1% | 10.4B-22.7% | 13.4B-14.6% | 15.7B+17.3% | |
| Acquisitions | 436M+358.9% | 95.0M-99.4% | 16.6B+11851.1% | 139M-4.8% | 146M-83.1% | |
| Purchases of investments | 15.0B-1.2% | 15.2B+68.0% | 9.04B+16.7% | 7.75B-22.3% | 9.96B+3.4% | |
| Other investing activities | -26.0M+74.3% | -101M-48.5% | -68.0M+20.0% | -85.0M+30.3% | -122M | |
| -4.94B-335.2% | -1.14B-142.3% | 2.68B+125.5% | -10.5B+7.4% | -11.4B-47.6% | ||
| Long-term debt issued | 3.97B-49.8% | 7.91B-27.4% | 10.9B | 0.00-100.0% | 987M-90.1% | |
| Long-term debt repaid | 3.63B-24.0% | 4.77B+50.8% | 3.17B-24.8% | 4.21B-58.9% | 10.3B-34.4% | |
| Net short-term debt | — | — | — | — | 0.00 | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 0.00-100.0% | 3.02B+50.2% | 2.01B-42.5% | 3.50B | 0.00 | |
| Dividends paid | 3.40B+0.7% | 3.37B+7.7% | 3.13B+7.7% | 2.91B+10.7% | 2.63B+0.0% | |
| Other financing activities | 0.00-100.0% | 26.0M+112.9% | -201M-154.4% | -79.0M-151.0% | 155M-64.1% | |
| Net change in cash | -172M-147.9% | 359M+107.5% | -4.78B-878.5% | 614M-62.7% | 1.65B-37.5% | |
| Interest paid | 2.99B+2.8% | 2.91B+20.3% | 2.42B+8.0% | 2.24B-9.3% | 2.47B-15.0% | |
| Income taxes paid | 2.17B+27.2% | 1.70B-51.7% | 3.52B-14.4% | 4.12B+28.8% | 3.19B+9.1% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 101B+78.4% | 56.6B-44.3% | 102B-17.0% | 122B-9.6% | 135B+51.2% | |
| P/E | 57.1×+365.5% | 12.3×+4.2% | 11.8×-67.6% | 36.3×+114.5% | 16.9×+35.6% | |
| P/S | 0.3×+65.4% | 0.2×-48.0% | 0.3×-24.8% | 0.4×-16.2% | 0.5×+39.1% | |
| P/B | 1.3×+79.2% | 0.7×-45.2% | 1.4×-21.1% | 1.7×-3.9% | 1.8×+39.7% | |
| P/FCF | 12.9×+44.5% | 8.9×-0.5% | 9.0×+43.2% | 6.3×-27.0% | 8.6×+28.9% | |
| Earnings yield | 1.8%-78.5% | 8.2%-4.0% | 8.5%+208.3% | 2.8%-53.4% | 5.9%-26.3% | |
| FCF yield | 7.7%-30.8% | 11.2%+0.5% | 11.1%-30.1% | 15.9%+36.9% | 11.6%-22.4% | |
| Dividend yield | 3.4%-43.4% | 5.9%+93.3% | 3.1%+29.8% | 2.4%+21.8% | 1.9%-33.8% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: CVS’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all CVS filings on SEC EDGAR → Not investment advice.